Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

Table 4 Results of Cox regression analyses

Outcome	Definitive treatment	n	Crude hazard ratio (95% CI)	Adjusted hazard ratio (95% CI)
30 day mortality	Carbapenem	20	1	1
30 day mortality	BLBLI	21	0.47 (0.09 to 2.59)	0.91 (0.13 to 6.28)*
Resolution of SIRS	Carbapenem	14	1	1
Resolution of SIRS	BLBLI	14	1.19 (0.44 to 3.19)	0.91 (0.32 to 2.59)*
Hospital discharge	Carbapenem	16	1	1
Hospital discharge	BLBLI	16	0.74 (0.38 to 1.41)	0.62 (0.27 to 1.42)*

ISSN: 2047-2994